166 related articles for article (PubMed ID: 32336244)
1. Further Development of Near-Infrared Mediated Quantum Dots and Paclitaxel Co-loaded Nanostructured Lipid Carrier System for Cancer Theragnostic.
Olerile LD
Technol Cancer Res Treat; 2020; 19():1533033820914308. PubMed ID: 32336244
[TBL] [Abstract][Full Text] [Related]
2. Near-infrared mediated quantum dots and paclitaxel co-loaded nanostructured lipid carriers for cancer theragnostic.
Olerile LD; Liu Y; Zhang B; Wang T; Mu S; Zhang J; Selotlegeng L; Zhang N
Colloids Surf B Biointerfaces; 2017 Feb; 150():121-130. PubMed ID: 27907859
[TBL] [Abstract][Full Text] [Related]
3. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
[TBL] [Abstract][Full Text] [Related]
4. Facile preparation of biocompatible nanostructured lipid carrier with ultra-small size as a tumor-penetration delivery system.
Zhao X; Tang D; Yang T; Wang C
Colloids Surf B Biointerfaces; 2018 Oct; 170():355-363. PubMed ID: 29940502
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel-loaded Nanolipidic Carriers with Improved Oral Bioavailability and Anticancer Activity against Human Liver Carcinoma.
Harshita ; Barkat MA; Rizwanullah M; Beg S; Pottoo FH; Siddiqui S; Ahmad FJ
AAPS PharmSciTech; 2019 Jan; 20(2):87. PubMed ID: 30675689
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer.
Yang XY; Li YX; Li M; Zhang L; Feng LX; Zhang N
Cancer Lett; 2013 Jul; 334(2):338-45. PubMed ID: 22776563
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect.
Wang Y; Zhang H; Hao J; Li B; Li M; Xiuwen W
Drug Deliv; 2016 May; 23(4):1398-403. PubMed ID: 26079530
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization and radiolabeling of folic acid modified nanostructured lipid carriers as a contrast agent and drug delivery system.
Ucar E; Teksoz S; Ichedef C; Kilcar AY; Medine EI; Ari K; Parlak Y; Sayit Bilgin BE; Unak P
Appl Radiat Isot; 2017 Jan; 119():72-79. PubMed ID: 27866122
[TBL] [Abstract][Full Text] [Related]
9. Nanocarrier-Based Combination Chemotherapy for Resistant Tumor: Development, Characterization, and Ex Vivo Cytotoxicity Assessment.
Raikwar S; Vyas S; Sharma R; Mody N; Dubey S; Vyas SP
AAPS PharmSciTech; 2018 Nov; 19(8):3839-3849. PubMed ID: 30280350
[TBL] [Abstract][Full Text] [Related]
10. Construction and in vitro and in vivo evaluation of folic acid-modified nanostructured lipid carriers loaded with paclitaxel and chlorin e6.
Zhang Q; Zhao J; Hu H; Yan Y; Hu X; Zhou K; Xiao S; Zhang Y; Feng N
Int J Pharm; 2019 Oct; 569():118595. PubMed ID: 31394189
[TBL] [Abstract][Full Text] [Related]
11. Formulation design and evaluation of quantum dot-loaded nanostructured lipid carriers for integrating bioimaging and anticancer therapy.
Hsu SH; Wen CJ; Al-Suwayeh SA; Huang YJ; Fang JY
Nanomedicine (Lond); 2013 Aug; 8(8):1253-69. PubMed ID: 23384703
[TBL] [Abstract][Full Text] [Related]
12. Intracellular delivery of 10-hydroxycamptothecin with targeted nanostructured lipid carriers against multidrug resistance.
Liu M; Chen D; Mukerabigwi JF; Chen S; Zhang Y; Lei S; Luo S; Wen Z; Cao Y; Huang X; He H
J Drug Target; 2016; 24(5):433-40. PubMed ID: 26422582
[TBL] [Abstract][Full Text] [Related]
13. Development and optimization of transferrin-conjugated nanostructured lipid carriers for brain delivery of paclitaxel using Box-Behnken design.
Emami J; Rezazadeh M; Sadeghi H; Khadivar K
Pharm Dev Technol; 2017 May; 22(3):370-382. PubMed ID: 27689412
[TBL] [Abstract][Full Text] [Related]
14. Photo-responsive and NGR-mediated multifunctional nanostructured lipid carrier for tumor-specific therapy.
Yang Y; Xie X; Yang Y; Zhang H; Mei X
J Pharm Sci; 2015 Apr; 104(4):1328-39. PubMed ID: 25630979
[TBL] [Abstract][Full Text] [Related]
15. Improved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumors.
Ye J; Liu Y; Xia X; Meng L; Dong W; Wang R; Fu Z; Liu H; Han R
Oncol Rep; 2016 Jul; 36(1):399-409. PubMed ID: 27175803
[TBL] [Abstract][Full Text] [Related]
16. Nanostructured monolinolein miniemulsions as delivery systems: Role of the internal mesophase on cytotoxicity and cell internalization.
Guillot S; Méducin F; Poljak K; Malard V; Foucault-Collet A; Serieye S; Pichon C
Int J Pharm; 2017 May; 523(1):142-150. PubMed ID: 28284919
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
[TBL] [Abstract][Full Text] [Related]
18. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells.
Zhou J; Sun M; Jin S; Fan L; Zhu W; Sui X; Cao L; Yang C; Han C
Drug Deliv; 2019 Dec; 26(1):281-289. PubMed ID: 30880491
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles.
Lee MK; Lim SJ; Kim CK
Biomaterials; 2007 Apr; 28(12):2137-46. PubMed ID: 17257668
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol loaded functionalized nanostructured lipid carriers for breast cancer targeting: Systematic development, characterization and pharmacokinetic evaluation.
Poonia N; Kaur Narang J; Lather V; Beg S; Sharma T; Singh B; Pandita D
Colloids Surf B Biointerfaces; 2019 Sep; 181():756-766. PubMed ID: 31234063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
